(3S,8R,9S,10R,13S,14S)-17-Ethyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
| Product Name |
(3S,8R,9S,10R,13S,14S)-17-Ethyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
|
| Product Code |
DA-A008-10
|
| Chemical name |
(3S,8R,9S,10R,13S,14S)-17-Ethyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
|
| Synonyms |
Pregna-5,16-dien-3B-ol acetate;
|
| Impurity |
NA
|
| CAS Number |
2118-32-3
|
| Alternate CAS # |
NA
|
| Molecular form |
C23H34O2
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
342.52
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals
|
| Boiling Point |
NA
|
| Applications |
Pregna-5,16-dien-3β-ol Acetate is an impurity of Abiraterone, a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor , is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. (Abiraterone Impurity 4).
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
